Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03513289 · ClinicalTrials.gov registry record
Collaborative Assessment of ICU Recovery Needs
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 66
- Enrollment target
NCT03513289: Completed study, sponsored by Vanderbilt University Medical Center.
NCT03513289 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 66 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03513289 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
Study Summary
The primary purpose of this study is to better understand the impact of the Society of Critical Care Medicine (SCCM) THRIVE Collaboratives on patients, their families and clinicians. The investigators have formed an international and interprofessional evaluative team with experts in the field in an effort to explore interactions between survivors and THRIVE. This approach is reflective of the international ethos of SCCM and its collaboratives, with the potential to improve the generalizability of this survivorship research to different health systems.
Primary Outcome
30-minute audio-taped, semi-structured interviews with patients informing on post-ICU care coordination
Interventions
- OTHER Patient, Carer, and Clinician Interviews
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2018-04-03 |
| Est. Completion | 2019-03-15 |
What the finished NCT03513289 record still lists
NCT03513289 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 66 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Patient, Carer, and Clinician Interviews is the first listed.
NCT03513289 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03513289 about?
NCT03513289 is a clinical study titled "Collaborative Assessment of ICU Recovery Needs". The primary purpose of this study is to better understand the impact of the Society of Critical Care Medicine (SCCM) THRIVE Collaboratives on patients, their families and clinicians. The investigators have formed an international and interprofessional evaluative team with experts in the field in an...
What is the current status of trial NCT03513289?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2018-04-03. Estimated completion is 2019-03-15.
What interventions are being tested in trial NCT03513289?
The interventions under investigation include: Patient, Carer, and Clinician Interviews (OTHER).
Who is sponsoring clinical trial NCT03513289?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI